QPPV.COM KNOWLEDGE ASSESSMENT

Vendor Oversight in Pharmacovigilance: Professional Knowledge Assessment

Test your understanding of the concepts covered by Vendor Oversight in Pharmacovigilance.

Question 1 of 10Pass mark: 80%

Question 1 of 10 When applying global vendor oversight principles across the EU, United States, United Kingdom, Japan and Canada, which approach is most appropriate?

Use one process without considering local reporting obligations. Maintain common global governance principles while adapting reporting formats, timelines and local requirements to each jurisdiction. Allow each vendor to select the regulatory requirements it will follow. Apply only the requirements of the vendor's country of operation.

Question 2 of 10 Which situation most clearly demonstrates that an SDEA exists but is not being effectively implemented?

The SDEA contains measurable timelines and the MAH routinely reconciles transmissions against performance reports. The SDEA assigns escalation within a defined period, but incidents are repeatedly escalated late and no governance action is documented. The SDEA includes audit rights and a risk-based audit is completed. The SDEA is reviewed through formal change control after a process change.

Question 3 of 10 Which evidence trail best demonstrates mature handling of a vendor-related ICSR reporting failure?

A single email asking the vendor to improve A KPI signal, documented escalation, root-cause investigation, targeted audit, CAPA, effectiveness verification, governance review and QPPV notification A revised vendor invoice and a closed meeting invitation A decision to stop measuring timeliness

Question 4 of 10 Which sequence best represents a complete vendor oversight lifecycle?

Selection, contracting, oversight, qualification, exit and onboarding Identification, qualification, selection, contracting, onboarding, oversight, review and exit Contracting, onboarding, selection, audit, termination and qualification Identification, selection, outsourcing, inspection and automatic renewal

Question 5 of 10 Which audit strategy is most consistent with the article's risk-based approach?

Audit all vendors annually using the same scope. Use more frequent and comprehensive audits for critical vendors, with proportionate remote or desk-based reviews for lower-risk vendors. Audit only vendors that have already caused a regulatory finding. Perform audits only when the contract requires a specific calendar date.

Question 6 of 10 Why should an SDEA include explicit subcontracting controls?

Subcontractors are outside the scope of pharmacovigilance oversight. Uncontrolled subcontracting can create additional accountability, quality, data-access and continuity risks that the MAH may not otherwise see. Subcontracting automatically makes the primary vendor noncompliant. The MAH must manage every subcontractor's daily work directly.

Question 7 of 10 Which feature makes a vendor KPI most useful during governance review?

It is reported without a threshold or trend information. It is linked to compliance or patient safety, trended over time and connected to defined actions when performance deteriorates. It measures only the number of meetings held. It is selected solely because the vendor already reports it.

Question 8 of 10 A vendor consistently meets average monthly timeliness targets, but regional reporting shows repeated late submissions for one product. What is the best professional interpretation?

The vendor is fully compliant because the overall average is acceptable. Aggregated performance may conceal a material localized risk, so the MAH should investigate product- and region-level trends and assess escalation. The regional results should be excluded because only global metrics matter. The MAH should lower the regional target to match the global average.

Question 9 of 10 An audit identifies a recurring case-quality failure. Which evidence best demonstrates that the MAH has managed the finding effectively?

A statement that the vendor has acknowledged the finding A documented root-cause analysis, SMART CAPA, assigned deadlines and verification showing that the corrective action was effective A new contract signed with the same vendor Removal of the finding from the next KPI report

Question 10 of 10 Which activity is most appropriate for a recurring ongoing oversight review rather than only initial qualification?

Verifying the vendor's ownership structure for the first time Reviewing current KPI trends, open CAPAs, subcontractor changes, data reconciliations and recent system or personnel changes Selecting a vendor before the need and scope are defined Negotiating the initial commercial proposal

Vendor Oversight in Pharmacovigilance: Professional Knowledge Assessment

Cookie Settings